Pronounced: nu-born JAWN-diss
by Cynthia M. Johnson, MA
Jaundice is a yellow coloring in your baby’s skin, and sometimes, the whites of the eyes. Newborn jaundice happens during the first weeks of life.
The yellow coloring is caused by bilirubin. Bilirubin is a waste product. The body makes it when red blood cells are broken down. Bilirubin normally passes out of the body through feces or urine. Jaundice happens when there is a buildup of bilirubin. This can happen when:
Newborn jaundice is more common in East Asian babies as well as babies who are very sick or born early. It is also more common in babies who have a sibling who was treated for jaundice. Other things that may raise the risk are:
The main symptom of jaundice is yellow skin color. It often starts in the face and may spread to the stomach and legs.
All babies are checked for jaundice at birth and at 3 to 5 days of age. The doctor will ask about your baby’s symptoms and health history. A physical exam will be done. It will focus on the baby's skin.
Tests may be:
Most babies will not need treatment. Jaundice often goes away in 2 to 3 weeks. Babies who do need treatment may need:
Increased breastfeeding can help clear bilirubin from a baby's body. Babies who are formula-fed will need to get extra formula.
Phototherapy uses special lights to change the bilirubin in the blood. The bilirubin can then pass in the urine or stool.
Babies with severe jaundice may need a blood transfusion. This will replace the baby’s blood with new blood. The excess bilirubin will be removed with the blood.
Newborn jaundice cannot always be prevented. The risk can be lowered by frequent feedings in the first several days after birth.
Healthy Children—American Academy of Pediatrics
March of Dimes
Public Health Agency of Canada
Infant jaundice. Family Doctor—American Academy of Family Physicians website. Available at: https://familydoctor.org/condition/infant-jaundice. Updated August 7, 2018. Accessed January 7, 2020.
Jaundice in healthy newborns. Kids Health—Nemours Foundation website. Available at:
...(Click grey area to select URL)
Updated April 2019. Accessed January 7, 2020.
Maisels MJ, Watchko JF, et al. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol. 2012 Sep;32(9):660-664.
Neonatal cholestasis. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/neonatal-cholestasis-18. Updated March 14, 2017. Accessed September 21, 2017.
Neonatal hyperbilirubinemia. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/neonatal-hyperbilirubinemia. Updated September 23, 2019. Accessed January 7, 2020.
Neonatal hyperbilirubinemia. Merck Manual Professional Version website. Available at:
...(Click grey area to select URL)
Updated December 2018. Accessed January 7, 2020.
Last reviewed September 2019 by EBSCO Medical Review Board Kari Kassir, MD
Last Updated: 7/28/2020
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.